Epilepsy often begins in childhood and can cause shortened life span, the risk of intellectual impairment and a reduced quality of life; therefore, research is extremely important.
Researchers at Wake Forest School of Medicine (WFSM) are studying the impact of epilepsy on attention, memory, learning and behavior in children, as well as the relationships between head injuries and seizures and between brain damage and the length, outcome and treatment of epilepsy.
Current research includes studies of new medications, genetic factors and seizure behavior.
Current Faculty Members Involved in Research:
Maria Sam, MD
Cormac O'Donovan, MD
Jane Boggs, MD
Gautam Popli, MBBS
CURRENT CLINICAL TRIALS
2009-Present: A long-term extension study to evaluate efficacy and safety of Eslicarbazepine Acetate in patients with Partial Onset Seizures, Sponsor: Sunovion Pharmaceuticals, Inc
2009-Present: A long-term trial in Epilepsy patients using a Responsive Neurostimulator System, Sponsor: Neuropace, Inc
2012-Present: UCB N01358-A study to evaluate the efficacy and safety of Brivaracetam in patients with Partial Onset Seizures, Sponsor: UCB Pharma, Inc
2012-Present: UCB N01379-A study to evaluate the long-term safety and efficacy of Brivaracetam in patients with Partial Onset Seizures, Sponsor: UCB Pharma, Inc
2012-Present: MONEAD-A study on the maternal outcomes and neurodevelopmental effects of antiepileptic drugs, Sponsor: NIH: National Institute of Neurological Disorders and Stroke; National Institute of Child Health and Human Development
2012-Present: An outcomes study to evaluate MR-guided laser ablation of epileptic foci, Sponsor: Visualase, Inc
Contact Information: Sara Vaughan, BA, CCRC, firstname.lastname@example.org, (336) 716-8694